Technetium-99m

Technetium-99m (Tc-99m) is a metastable nuclear isomer of technetium-99, a synthetic element with a significant application in nuclear medicine. Discovered in the 1930s by Emilio Segrè and Carlo Perrier, technetium was the first artificially produced element. Tc-99m, in particular, has become the most widely used radioisotope for medical imaging due to its favourable physical and radiological properties.

The primary reason behind Tc-99m widespread use in medical diagnostics is its ideal half-life of approximately six hours. This relatively short half-life allows for the rapid decay and elimination of the radioisotope from the patient’s body, minimizing radiation exposure. Additionally, Tc-99m emits gamma rays with an energy of 140 keV, which is optimal for detection by gamma cameras and single-photon emission computed tomography (SPECT) scanners. These properties enable physicians to obtain high-quality images while ensuring patient safety.

Technetium-99m is typically produced by irradiating a molybdenum-98 (Mo-98) target in a nuclear reactor, which then undergoes a nuclear reaction to form molybdenum-99 (Mo-99). Mo-99 decays to Tc-99m with a half-life of 66 hours, making it a practical generator-produced radioisotope. The Tc-99m is extracted from the Mo-99 through a straightforward chemical process, often called a ‘molybdenum cow’ or ‘technetium generator.’ The on-demand production of Tc-99m from Mo-99 allows healthcare facilities to continuously supply the radioisotope for diagnostic procedures.

One of the major advantages of Tc-99m is its ability to be complexed with various radiopharmaceuticals, allowing it to target specific organs or tissues in the body. For instance, Tc-99m can be combined with methylene diphosphonate (MDP) to assess bone metabolism or with diethylenetriaminepentaacetic acid (DTPA) for renal imaging. These radiopharmaceuticals facilitate the accumulation of Tc-99m in the desired tissue or organ, providing essential diagnostic information through gamma-ray detection.

Tc-99m is crucial in diagnosing various diseases and conditions, including cancer, heart disease, bone disorders, and thyroid issues. Some common imaging techniques using Tc-99m include SPECT, planar imaging, and SPECT/CT. These imaging modalities enable physicians to study the structure and function of organs, identify abnormalities, and monitor the progress of treatments.

You are here:
home » technetium-99m

FDA-approved radiopharmaceuticals revolutionise diagnostics and targeted therapies, enhancing accuracy and effectiveness in disease detection and treatment.
FDA-Approved Radiopharmaceuticals

Technetium-99m Sestamibi in Cardiac Diagnostics: Myocardial Perfusion and the Battle Against Coronary Artery Disease

Technetium-99m Sestamibi revolutionises cardiac care by precisely mapping blood flow in diagnosing coronary artery disease.

Technetium-99m Sestamibi in Cardiac Diagnostics: Myocardial Perfusion and the Battle Against Coronary Artery Disease Read Post »

FDA-approved radiopharmaceuticals revolutionise diagnostics and targeted therapies, enhancing accuracy and effectiveness in disease detection and treatment.
FDA-Approved Radiopharmaceuticals

Technetium-99m Exametazime (Ceretec): Overview of its Applications, Advantages, and Role in Medical Imaging

Technetium-99m exametazime (Ceretec) is a pivotal radiopharmaceutical in nuclear medicine, revolutionising brain imaging with high precision and reliability.

Technetium-99m Exametazime (Ceretec): Overview of its Applications, Advantages, and Role in Medical Imaging Read Post »

FDA-approved radiopharmaceuticals revolutionise diagnostics and targeted therapies, enhancing accuracy and effectiveness in disease detection and treatment.
FDA-Approved Radiopharmaceuticals

Technetium-99m Bicisate (Neurolite): A Radiopharmaceutical Beacon in Stroke Localisation and Management

Technetium-99m bicisate (Neurolite) facilitates stroke diagnosis by enabling cerebral perfusion imaging, aiding in locating affected brain regions.

Technetium-99m Bicisate (Neurolite): A Radiopharmaceutical Beacon in Stroke Localisation and Management Read Post »

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Accept
Decline
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active
This privacy and cookies policy sets out how Open Medscience uses and protects any information that you give Open Medscience when you use this website (https://openmedscience.com). Open Medscience is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified when using this website, you can be assured that it will only be used according to this privacy statement. Open Medscience may change this policy from time to time by updating this page. You should check this page from time to time to ensure that you are happy with any changes. This policy is effective from 19 July 2022.

How we use cookies

A cookie is a small file that asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences. We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes and then the data is removed from the system. Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us. You can choose to accept or decline cookies. Most web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. This may prevent you from taking full advantage of the website. Our website (https://openmedscience.com) may contain links to other websites of interest. However, once you have used these links to leave our site, you should note that we do not have any control over that other website. Therefore, we cannot be responsible for the protection and privacy of any information which you provide whilst visiting such sites and such sites are not governed by this privacy statement. You should exercise caution and look at the privacy statement applicable to the website in question. You are here: home » technetium-99m
Save settings
Cookies settings
Scroll to Top